Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX4211 (Sotagliflozin) + Metformin in T2DM
NCT01376557Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jun 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Lexicon Pharmaceuticals, Inc.. Started Jun 2011; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01376557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376557.